動物用ワクチンのアジア太平洋市場2020-2102

◆英語タイトル:ASIA PACIFIC VETERINARY VACCINES MARKET FORECAST 2020-2028
◆商品コード:INK20MY153
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年2月
◆ページ数:163
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:アジア太平洋
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥137,500見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD2,000 ⇒換算¥220,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

KEY FINDINGS The Asia Pacific market region, with regard to veterinary vaccines, is predicted to register a CAGR of 6.25% over the estimated period of 2020-2028. The important factors boosting the market growth are a wide range of product launches and investments in vaccine manufacturing facilities, especially in China, India, and Thailand.

MARKET INSIGHTS
The Asia Pacific veterinary vaccines market is further analyzed by segregating the region into countries such as South Korea, China, Australia & New Zealand, Indonesia, India, Japan, Vietnam, Thailand, and the rest of Asia Pacific that includes Malaysia, Philippines, Singapore, and Cambodia. In South Korea, the increasing prevalence of animal diseases, coupled with various initiatives related to vaccination for animals, is propelling the growth of the market in this region. In countries like Thailand, drug law regulates both human and veterinary medicinal products. All medical products require licensing for manufacturing, selling, importing, and registration. The swine industry is huge in Thailand and is plagued by viral epidemics. The country imports all of its animal vaccines at present, but they are often ineffective, driving the demand for the market. In Indonesia, traditionally, poultry plays a major role in the lives of its people. Poultry contributes 60% of the national meat supply. In keeping with the increased demand for poultry meat, Indonesia continued to contribute to the improved health of poultry. Vietnam has managed to eradicate most of the diseases like bird flu, blue ear, or foot and mouth disease among cattle and poultry, according to the Department of Animal Health. In the rest of the Asia Pacific region, growth in the vaccines market can be attributed to the growing livestock population, increasing awareness about animal health and zoonotic diseases, and the frequent outbreaks of animal diseases in these regions.

COMPETITIVE INSIGHTS
Elanco, Virbac SA, Hester Biosciences Ltd., Zoetis Inc., Merck & Co., Inc., etc. are some of the leading companies operating in the market.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARIES
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. MARKET DEFINITION
3.2. KEY DRIVERS
3.2.1. PROGRESSION IN THE VACCINE PRODUCTS
3.2.2. INCREASING GOVERNMENT INITIATIVES
3.2.3. INCREASING INCIDENCE OF ZOONOTIC DISEASES
3.2.4. SURGE IN THE COMPANION ANIMAL OWNERSHIP
3.2.5. GROWING PREVALENCE OF LIVESTOCK DISEASES
3.3. KEY RESTRAINTS
3.3.1. HIGH COST OF VACCINATIONS
3.3.2. SIDE EFFECTS ASSOCIATED WITH VETERINARY VACCINES ON HUMAN AND ANIMAL HEALTH
3.3.3. LACK OF SKILLED FARMWORKERS AND VETERINARIANS
4. KEY ANALYTICS
4.1. PORTER’S FIVE FORCE ANALYSIS
4.1.1. THREAT OF NEW ENTRY
4.1.2. THREAT OF SUBSTITUTION
4.1.3. BUYER’S POWER
4.1.4. SUPPLIER’S POWER
4.1.5. COMPETITIVE RIVALRY
4.2. VALUE CHAIN ANALYSIS
4.3. REGULATORY FRAMEWORK
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
5. MARKET BY VACCINE TYPE
5.1. LIVESTOCK VACCINE
5.1.1. PORCINE VACCINE
5.1.2. BOVINE VACCINE
5.1.3. POULTRY VACCINE
5.1.4. AQUACULTURE VACCINE
5.1.5. OTHER LIVESTOCK VACCINE
5.2. COMPANION VACCINE
5.2.1. CANINE VACCINE
5.2.2. FELINE VACCINE
5.2.3. EQUINE VACCINE
6. MARKET BY TECHNOLOGY
6.1. LIVE ATTENUATED VACCINE
6.2. INACTIVATED VACCINE
6.3. RECOMBINANT VACCINE
6.4. TOXOID VACCINE
6.5. OTHER TECHNOLOGY
7. MARKET BY DISEASE TYPE
7.1. CANINE DISEASE
7.2. PORCINE DISEASE
7.3. BOVINE DISEASE
7.4. POULTRY DISEASE
7.5. AQUACULTURE DISEASE
7.6. OTHER DISEASE TYPE
8. GEOGRAPHICAL ANALYSIS
8.1. ASIA PACIFIC
8.1.1. CHINA
8.1.2. JAPAN
8.1.3. INDIA
8.1.4. AUSTRALIA & NEW ZEALAND
8.1.5. SOUTH KOREA
8.1.6. THAILAND
8.1.7. INDONESIA
8.1.8. VIETNAM
8.1.9. REST OF ASIA PACIFIC
9. COMPANY PROFILES
9.1. ANICON LABOR GMBH
9.2. BOEHRINGER INGELHEIM ANIMAL HEALTH GMBH
9.3. CEVA SANTE ANIMALE
9.4. ELANCO (ELI LILLY AND COMPANY)
9.5. HESTER BIOSCIENCES LIMITED
9.6. HIPRA
9.7. HYGIEIA BIOLOGICAL LABORATORIES
9.8. MERCK & CO.
9.9. PHIBRO ANIMAL HEALTH CORP.
9.10. ROMVAC COMPANY S.A.
9.11. VAXXINOVA GMBH-GERMANY
9.12. VIRBAC SA
9.13. ZOETIS ANIMAL HEALTHCARE

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – VETERINARY VACCINE
TABLE 2: ASIA PACIFIC VETERINARY VACCINES, BY VACCINE TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: ASIA PACIFIC VETERINARY VACCINES, BY VACCINE TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 4: ASIA PACIFIC LIVESTOCK VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: ASIA PACIFIC LIVESTOCK VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 6: ASIA PACIFIC LIVESTOCK VACCINE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: ASIA PACIFIC LIVESTOCK VACCINE MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 8: ASIA PACIFIC PORCINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: COMMERCIALLY AVAILABLE PORCINE VACCINES
TABLE 10: ASIA PACIFIC PORCINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 11: ASIA PACIFIC BOVINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 12: COMMERCIALLY AVAILABLE BOVINE VACCINES
TABLE 13: ASIA PACIFIC BOVINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 14: ASIA PACIFIC POULTRY VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 15: COMMERCIALLY AVAILABLE POULTRY VACCINES
TABLE 16: ASIA PACIFIC POULTRY VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 17: ASIA PACIFIC AQUACULTURE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 18: COMMERCIALLY AVAILABLE AQUACULTURE VACCINES
TABLE 19: ASIA PACIFIC AQUACULTURE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 20: ASIA PACIFIC OTHER LIVESTOCK VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 21: ASIA PACIFIC OTHER LIVESTOCK VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 22: ASIA PACIFIC COMPANION VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 23: ASIA PACIFIC COMPANION VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 24: ASIA PACIFIC COMPANION VACCINE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 25: ASIA PACIFIC COMPANION VACCINE MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 26: ASIA PACIFIC CANINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 27: COMMERCIALLY AVAILABLE CANINE VACCINES
TABLE 28: ASIA PACIFIC CANINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 29: ASIA PACIFIC FELINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 30: COMMERCIALLY AVAILABLE FELINE VACCINES
TABLE 31: ASIA PACIFIC FELINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 32: ASIA PACIFIC EQUINE VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 33: COMMERCIALLY AVAILABLE EQUINE VACCINES
TABLE 34: ASIA PACIFIC EQUINE VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 35: ASIA PACIFIC VETERINARY VACCINES, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 36: ASIA PACIFIC VETERINARY VACCINES, BY TECHNOLOGY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 37: ASIA PACIFIC LIVE ATTENUATED VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 38: ASIA PACIFIC LIVE ATTENUATED VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 39: ASIA PACIFIC INACTIVATED VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 40: ASIA PACIFIC INACTIVATED VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 41: ASIA PACIFIC RECOMBINANT VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 42: ASIA PACIFIC RECOMBINANT VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 43: ASIA PACIFIC TOXOID VACCINE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 44: ASIA PACIFIC TOXOID VACCINE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 45: ASIA PACIFIC OTHER TECHNOLOGY MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 46: ASIA PACIFIC OTHER TECHNOLOGY MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 47: ASIA PACIFIC VETERINARY VACCINES, BY DISEASE TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 48: ASIA PACIFIC VETERINARY VACCINES, BY DISEASE TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 49: ASIA PACIFIC CANINE DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 50: ASIA PACIFIC CANINE DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 51: ASIA PACIFIC PORCINE DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 52: ASIA PACIFIC PORCINE DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 53: ASIA PACIFIC BOVINE DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 54: ASIA PACIFIC BOVINE DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 55: ASIA PACIFIC POULTRY DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 56: ASIA PACIFIC POULTRY DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 57: ASIA PACIFIC AQUACULTURE DISEASE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 58: ASIA PACIFIC AQUACULTURE DISEASE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 59: ASIA PACIFIC OTHER DISEASE TYPE MARKET, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 60: ASIA PACIFIC OTHER DISEASE TYPE MARKET, FORECAST YEARS, 2020-2028 (IN $ MILLION)
TABLE 61: ASIA PACIFIC VETERINARY VACCINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 62: ASIA PACIFIC VETERINARY VACCINE MARKET, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)
LIST OF FIGURES
FIGURE 1: PORTER’S FIVE FORCE ANALYSIS
FIGURE 2: OPPORTUNITY MATRIX
FIGURE 3: VENDOR LANDSCAPE
FIGURE 4: ASIA PACIFIC VETERINARY VACCINES, BY VACCINE TYPE, IN 2019
FIGURE 5: ASIA PACIFIC VETERINARY VACCINES MARKET, BY LIVESTOCK VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 6: ASIA PACIFIC LIVESTOCK VACCINE MARKET, BY PORCINE VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 7: ASIA PACIFIC LIVESTOCK VACCINE MARKET, BY BOVINE VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 8: ASIA PACIFIC LIVESTOCK VACCINE MARKET, BY POULTRY VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 9: ASIA PACIFIC LIVESTOCK VACCINE MARKET, BY AQUACULTURE VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 10: ASIA PACIFIC LIVESTOCK VACCINE MARKET, BY OTHER LIVESTOCK VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 11: ASIA PACIFIC VETERINARY VACCINES MARKET, BY COMPANION VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 12: ASIA PACIFIC COMPANION VACCINE MARKET, BY CANINE VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 13: ASIA PACIFIC COMPANION VACCINE MARKET, BY FELINE VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 14: ASIA PACIFIC COMPANION VACCINE MARKET, BY EQUINE VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 15: ASIA PACIFIC VETERINARY VACCINES, BY TECHNOLOGY, IN 2019
FIGURE 16: ASIA PACIFIC VETERINARY VACCINES MARKET, BY LIVE ATTENUATED VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 17: ASIA PACIFIC VETERINARY VACCINES MARKET, BY INACTIVATED VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 18: ASIA PACIFIC VETERINARY VACCINES MARKET, BY RECOMBINANT VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 19: ASIA PACIFIC VETERINARY VACCINES MARKET, BY TOXOID VACCINE, 2020-2028 (IN $ MILLION)
FIGURE 20: ASIA PACIFIC VETERINARY VACCINES MARKET, BY OTHER TECHNOLOGY, 2020-2028 (IN $ MILLION)
FIGURE 21: ASIA PACIFIC VETERINARY VACCINES, BY DISEASE TYPE, IN 2019
FIGURE 22: ASIA PACIFIC VETERINARY VACCINES MARKET, BY CANINE DISEASE, 2020-2028 (IN $ MILLION)
FIGURE 23: ASIA PACIFIC VETERINARY VACCINES MARKET, BY PORCINE DISEASE, 2020-2028 (IN $ MILLION)
FIGURE 24: ASIA PACIFIC VETERINARY VACCINES MARKET, BY BOVINE DISEASE, 2020-2028 (IN $ MILLION)
FIGURE 25: ASIA PACIFIC VETERINARY VACCINES MARKET, BY POULTRY DISEASE, 2020-2028 (IN $ MILLION)
FIGURE 26: ASIA PACIFIC VETERINARY VACCINES MARKET, BY AQUACULTURE DISEASE, 2020-2028 (IN $ MILLION)
FIGURE 27: ASIA PACIFIC VETERINARY VACCINES MARKET, BY OTHER DISEASE TYPE, 2020-2028 (IN $ MILLION)
FIGURE 28: ASIA PACIFIC VETERINARY VACCINE MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
FIGURE 29: CHINA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
FIGURE 30: JAPAN VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
FIGURE 31: INDIA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
FIGURE 32: AUSTRALIA & NEW ZEALAND VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
FIGURE 33: SOUTH KOREA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
FIGURE 34: THAILAND VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
FIGURE 35: INDONESIA VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
FIGURE 36: VIETNAM VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)
FIGURE 37: REST OF ASIA PACIFIC VETERINARY VACCINE MARKET, 2020-2028 (IN $ MILLION)



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[動物用ワクチンのアジア太平洋市場2020-2102]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆